Advanced Nonhematological Malignancies
2 clinical trials · Condition
◉ Watch Advanced Nonhematological Malignancies
| Record | Firm | Date |
|---|---|---|
| Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies (NCT01179399) | Millennium Pharmaceuticals, Inc. | 2010-09-01 |
| Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies (NCT01045421) | Millennium Pharmaceuticals, Inc. | 2010-02-01 |
Track Advanced Nonhematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.